HOWL
Price
$1.31
Change
-$0.05 (-3.68%)
Updated
Jun 4 closing price
Capitalization
58.78M
63 days until earnings call
TRDA
Price
$8.16
Change
+$0.23 (+2.90%)
Updated
Jun 5, 03:17 PM (EDT)
Capitalization
300.97M
62 days until earnings call
Interact to see
Advertisement

HOWL vs TRDA

Header iconHOWL vs TRDA Comparison
Open Charts HOWL vs TRDABanner chart's image
Werewolf Therapeutics
Price$1.31
Change-$0.05 (-3.68%)
Volume$472.05K
Capitalization58.78M
Entrada Therapeutics
Price$8.16
Change+$0.23 (+2.90%)
Volume$601
Capitalization300.97M
HOWL vs TRDA Comparison Chart
Loading...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOWL vs. TRDA commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOWL is a Hold and TRDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (HOWL: $1.31 vs. TRDA: $7.93)
Brand notoriety: HOWL and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOWL: 109% vs. TRDA: 67%
Market capitalization -- HOWL: $58.78M vs. TRDA: $300.97M
HOWL [@Biotechnology] is valued at $58.78M. TRDA’s [@Biotechnology] market capitalization is $300.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOWL’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • HOWL’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both HOWL and TRDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOWL’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • HOWL’s TA Score: 5 bullish, 4 bearish.
  • TRDA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both HOWL and TRDA are a good buy in the short-term.

Price Growth

HOWL (@Biotechnology) experienced а +7.38% price change this week, while TRDA (@Biotechnology) price change was +2.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.83%. For the same industry, the average monthly price growth was +10.67%, and the average quarterly price growth was -1.74%.

Reported Earning Dates

HOWL is expected to report earnings on Aug 07, 2025.

TRDA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($301M) has a higher market cap than HOWL($58.8M). HOWL YTD gains are higher at: -11.486 vs. TRDA (-54.135). TRDA has higher annual earnings (EBITDA): 7.89M vs. HOWL (-65.72M). TRDA has more cash in the bank: 383M vs. HOWL (92M). HOWL has less debt than TRDA: HOWL (37M) vs TRDA (57M). TRDA has higher revenues than HOWL: TRDA (172M) vs HOWL (1.14M).
HOWLTRDAHOWL / TRDA
Capitalization58.8M301M20%
EBITDA-65.72M7.89M-833%
Gain YTD-11.486-54.13521%
P/E RatioN/A13.67-
Revenue1.14M172M1%
Total Cash92M383M24%
Total Debt37M57M65%
TECHNICAL ANALYSIS
Technical Analysis
HOWLTRDA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 14 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MVALX38.99N/A
N/A
Meridian Contrarian Legacy
SAMVX11.60N/A
N/A
Virtus Ceredex Mid-Cap Value Equity A
FDFIX25.53N/A
N/A
Fidelity Flex 500 Index
SAIEX9.53N/A
N/A
Spirit of America Energy Institutional
FSQZX10.54N/A
N/A
Fidelity Advisor Sustainable Intl Eq Z

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with GBIO. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-3.68%
GBIO - HOWL
43%
Loosely correlated
-2.86%
CLDX - HOWL
39%
Loosely correlated
-1.01%
ABOS - HOWL
39%
Loosely correlated
+2.88%
IPSC - HOWL
39%
Loosely correlated
-0.54%
VSTM - HOWL
38%
Loosely correlated
+4.58%
More